Clinical Trial Update: Synergetic B-cell Immunomodulation in SLE - 2nd Study. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on a synergetic B-cell immunomodulation approach for systemic lupus erythematosus; the study is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Leiden University Medical Center | Conditions: Lupus Erythematosus, Systemic | Phase 3 | Status: ACTIVE_NOT_RECRUITING